Slide Library

The slides listed below are of interest to melanoma healthcare professionals.

2023 Slides

The Management of In-Transit Melanoma
by Robert H.I. Andtbacka, MD, CM, FRCS(C)

Current Status of Adjuvant Interferon-α (IFN-α) Therapy in Melanoma
by Ahmad Tarhini, MD

The Role of Sentinel Lymph Node Biopsy (SLNB) in Prior Resected and Recurrent Melanoma
by Robert H.I. Andtbacka, MD, CM, FRCS(C)

Immunotherapy of Melanoma Using Checkpoint Blockade
by Jedd D. Wolchok, MD, PhD

Melanoma Brain Metastases
by Mark R. Middleton, PhD, FRCP

AJCC Melanoma Staging 2009: Impact on Current Practices
by Susan M. Swetter, MD

Genomics and Proteomics in Melanoma Biomarker Development
by Sancy Leachman, MD, PhD

Managing the Side Effects of Medical and Surgical Therapy To Keep the Patient on Therapy
by Krista M. Rubin, MS, RN, FNP-C

Targeted Therapy in Melanoma: Recent Progress
by Keith T. Flaherty, MD

2022 Slides

Managing adverse effects and improving patient compliance
by Rosemary Giuliano, ARNP, MSN

Methods of biopsy; Mohs micrographic surgery vs standard resection for MIS; and the value of imiquimod
by Clara Curiel-Lewandrowski, MD

SLNB: Decoding the controversies regarding its use and significance
by Robert H.I. Andtbacka, MD, CM, FRCS(C)

What's different about the 7th edition of the AJCC staging system?
by Merrick I. Ross, MD, FACS

Update on histologic and molecular markers for melanoma
by Mohammed Kashani-Sabet, MD

Signal Transduction Inhibitors in Melanoma: NOT One-Size-Fits-All
by Keith T. Flaherty, MD

Scientific and Clinical Interpretation of New Data on IFN-a for Adjuvant Therapy of Melanoma
by John M. Kirkwood, MD

Melanoma: A Mysterious Disease?
by Vernon Sondak, MD

The slide library is only available to registered users